ARCHIVES

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

NIH Investigating Cohn Records Leak

August 15, 1986

Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.

December 10, 2004

NCCS Networker Volume 3 Issue 2, Spring 1989

April 13, 1989

Rev/Vel/Dex Response Rate High In Phase I/II Study

January 25, 2008

NCI To Fund 160 P01s FY91, About same As Last Year; Considering New ‘Interactive’ R01

June 21, 1991

Q & A With Shannon Brownlee: Task Force Independence at Stake In Debate over PSA Screening

October 6, 2011